In relation to different breast cancer histological subtypes, CTCs detected by the EpCAM-independent method were more common in patients with HR-negative, as well as ERBB2-negative breast cancers as compared to patients with HR-positive or ERBB2-positive breast cancer, respectively (p < 0.05, G test). This evidence concerns the gene ERBB2 and breast carcinoma.